| Meade Medical Clinic Sc | |
|
134 Hospital Dr Watertown WI 53098-3304 | |
| (920) 261-6500 | |
| (920) 261-6693 |
| Full Name | Meade Medical Clinic Sc |
|---|---|
| Speciality | Clinic/Center |
| Location | 134 Hospital Dr, Watertown, Wisconsin |
| Authorized Official Name and Position | Jeffrey A Meade (PRESIDENT) |
| Authorized Official Contact | 9202616500 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Meade Medical Clinic Sc 134 Hospital Drive Watertown WI 53098 Ph: (920) 261-6500 | Meade Medical Clinic Sc 134 Hospital Dr Watertown WI 53098-3304 Ph: (920) 261-6500 |
| NPI Number | 1396817789 |
|---|---|
| Provider Enumeration Date | 11/14/2006 |
| Last Update Date | 10/29/2011 |
| Medicare PECOS PAC ID | 2365348026 |
|---|---|
| Medicare Enrollment ID | O20031211000954 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396817789 | NPI | - | NPPES |
| 32875700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Jeffrey A Meade |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1437156163 PECOS PAC ID: 3971409632 Enrollment ID: I20031211000995 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Provider Name | Scott A Martin |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1114914538 PECOS PAC ID: 8426038498 Enrollment ID: I20040721000574 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Provider Name | Kevin J Hayes |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1831140326 PECOS PAC ID: 4981785474 Enrollment ID: I20080123000174 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Provider Name | James E Meade |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528065257 PECOS PAC ID: 7517863277 Enrollment ID: I20101105000329 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Provider Name | Jan S Beyer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083013270 PECOS PAC ID: 4486874203 Enrollment ID: I20140930000569 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
| Provider Name | Caihong Zheng |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649946864 PECOS PAC ID: 4880082510 Enrollment ID: I20211028001481 |
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
News Archive
Men are more likely than women to experience many of the problems commonly associated with nondependent drinking, according to a new study.
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.
Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, heart problems and have lost weight. Despite having this disease at birth, these mice have a "secret weapon" in their youth that staves off signs of aging for a time.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
› Verified 1 days ago
Watertown Physician Practices Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 132 Hospital Dr, Watertown, WI 53098 Phone: 920-261-2020 Fax: 920-261-0457 | |
Turke Family Medicine, S.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 132 Hospital Dr, Watertown, WI 53098 Phone: 920-261-2020 Fax: 920-261-0457 | |
Watertown Internal Medicine Sc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 Hospital Dr, Suite 2009, Watertown, WI 53098 Phone: 920-262-9833 | |
Nagel Neighborhood Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 612 Mary Knoll Ln, Watertown, WI 53098 Phone: 920-631-1310 Fax: 920-335-3570 | |
Wolfe Mobile Medical Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 510 Grey Fox Run, Watertown, WI 53094 Phone: 920-253-5851 | |
Uwhp Wrmc House Calls Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 Hospital Dr, Ste 2004, Watertown, WI 53098 Phone: 920-253-1230 Fax: 920-262-4333 | |
Family Medical Care Associates, S.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 Hospital Dr, Suite 2004, Watertown, WI 53098 Phone: 920-206-7772 Fax: 920-206-1001 |